Jonathan Brammer
Physician · Ohio State University College of Medicine
Credentials: · · · · ·
History
- 2012–2015
Hematology and Medical Oncology
2005–2009
Research
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 169 citations
British Journal of Haematology · 2016 · 115 citations
Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade
Blood · 2019 · 94 citations
20 papers
- SP
18 papers
- JR
17 papers
17 papers
16 papers
16 papers
16 papers · 10 as a resident
- AS
13 papers
Grants
- 2024–2025
Mechanisms of Resistance and Therapeutic Targets in T-LGL Leukemia
National Cancer Institute · R03
Contact PI · $157.5K · Ohio State University
Clinical trials
- 2026–2027
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Principal investigator · Recruiting · Phase 2
Jonathan Brammer
- 2023–2026
Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
Principal investigator · Recruiting · Phase 2
Jonathan Brammer
- 2022–2026
Principal investigator · Active not recruiting · Phase 1, Phase 2
Jonathan Brammer
- 2018–2020
A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL
Principal investigator · Completed · Phase 1, Phase 2
Bioniz Therapeutics